Perioperative Therapy for Non-Small Cell Lung Cancer with Immune Checkpoint Inhibitors

SIMPLE SUMMARY: This review presents the development of perioperative treatment using immune checkpoint inhibitors (ICIs) in patients with resectable non-small cell lung cancers. There are several ongoing phase 3 trials for adjuvant and neoadjuvant ICI therapies. The results of the adjuvant (IMpower...

Descripción completa

Detalles Bibliográficos
Autores principales: Soh, Junichi, Hamada, Akira, Fujino, Toshio, Mitsudomi, Tetsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391213/
https://www.ncbi.nlm.nih.gov/pubmed/34439189
http://dx.doi.org/10.3390/cancers13164035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391213/
https://www.ncbi.nlm.nih.gov/pubmed/34439189
http://dx.doi.org/10.3390/cancers13164035

Ejemplares similares